Alkermes (ALKS) Return on Capital Employed (2011 - 2026)
Alkermes (ALKS) posted quarterly Return on Capital Employed of 3.2% for Q2 2026, down 1932.0% year-over-year from 0.17% in Q2 2025, and down 53.74% quarter-over-quarter from 6.92% in Q1 2026.
Alkermes (ALKS) Return on Capital Employed (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Return on Capital Employed for 16 consecutive years, with 3.2% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Capital Employed fell 1932.0% year-over-year to 3.2%; the TTM figure through Jun 2026 stood at 3.2% (down 1932.0% YoY), while the FY2025 annual figure was 14.7%, down 1110.0% from the prior year.
- Return on Capital Employed retreated to 3.2% in Q2 2026 per ALKS's latest filing, from 6.92% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 28.03% in Q1 2024 and bottomed at 0.42% in Q4 2022.
- Historically, Return on Capital Employed has averaged 14.57% across 5 years, with a median of 18.05% in 2024.
- Annual changes were most pronounced in 2024 — Return on Capital Employed soared 2737 bps — and 2026, when it plunged 1932 bps.
- Alkermes' Return on Capital Employed stood at 0.42% in 2022, then jumped by 5965 bps to 24.54% in 2023, then gained by 5 bps to 25.64% in 2024, then sank by 47 bps to 13.62% in 2025, then tumbled by 76 bps to 3.2% in 2026.
- Business Quant data shows ALKS's Return on Capital Employed at 3.2% in Q2 2026, 6.92% in Q1 2026, and 13.62% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 3.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.20% |
| Mar 31, 2026 | 6.92% |
| Dec 31, 2025 | 13.62% |
| Sep 30, 2025 | 19.73% |
| Jun 30, 2025 | 22.52% |
| Mar 31, 2025 | 24.07% |
| Dec 31, 2024 | 25.64% |
| Sep 30, 2024 | 18.10% |
| Jun 30, 2024 | 18.00% |
| Mar 31, 2024 | 28.03% |
| Dec 31, 2023 | 24.54% |
| Sep 30, 2023 | 27.46% |
| Jun 30, 2023 | 20.75% |
| Mar 31, 2023 | 0.66% |
| Dec 31, 2022 | -0.42% |
| Sep 30, 2022 | 0.52% |
| Jun 30, 2022 | 3.19% |
| Mar 31, 2022 | 5.69% |
| Dec 31, 2021 | 6.35% |
| Sep 30, 2021 | -4.12% |